New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules, peptides and antibodies being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can.
| Cat.No. | Product Name | Activity |
| 5395 | Virodhamine trifluoroacetate | TFA salt of virodhamine, an endogenous cannabinoid receptor mixed agonist/antagonist |
| 5314 | SMBA 1 | High affinity and selective activator of Bax |
| 5058 | ANAVEX 2-73 | Mixed σ1 and muscarinic receptor agonist; exhibits neuroprotective effects |
| 5011 | HMR 1556 | Potent and selective Iks channel blocker |
| 5357 | DC 260126 | FFA1 (GPR40) antagonist |
| 5347 | Kisspeptin 10 (dog) | Endogenous ligand for canine kisspeptin receptor |
| 5309 | SP 100030 | NF-κB and AP-1 dual inhibitor |
| 5297 | LY 404187 | Selective AMPA receptor positive allosteric modulator |
| 5286 | TC-S 7010 | Potent and selective Aurora kinase A inhibitor |
| 5209 | TAK 21d | Potent FAAH inhibitor |
| 4832 | AZ 12216052 | Positive allosteric modulator at mGlu8 |
| 4719 | VU 0463271 | Potent and selective inhibitor of the neuronal K-Cl cotransporter (KCC2) |
| 5276 | NS 19504 | Activator of BKCa (KCa1.1) channels |
| 5348 | CPI 613 | DH and KGDH inhibitor |
| 5294 | Oltipraz | Nrf2 activator |
| 5242 | CLP 257 | Selective KCC2 K+-Cl- cotransporter activator |
| 5237 | Bryostatin 2 | Protein kinase C activator |
| 5236 | CC4 | High affinity and subtype-selective α6β2 and α4β2 partial agonist |
| 4890 | AR-C 118925XX | Selective, competitive P2Y2 receptor antagonist |